On Target Laboratories

West Lafayette, United States Founded: 2010 • Age: 16 yrs
Molecular imaging agents for cancer surgery are developed.
Request Access

About On Target Laboratories

On Target Laboratories is a company based in West Lafayette (United States) founded in 2010 by Phil S Low.. On Target Laboratories has raised $116.5 million across 8 funding rounds from investors including Olympus, HHS and H.I.G. Capital. The company has 29 employees as of December 31, 2023. On Target Laboratories offers products and services including CYTALUX. On Target Laboratories operates in a competitive market with competitors including Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics, Averto Medical, Guerbet and C-RAD, among others.

  • Headquarter West Lafayette, United States
  • Employees 29 as on 31 Dec, 2023
  • Founders Phil S Low
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name On Target Laboratories, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $116.5 M (USD)

    in 8 rounds

  • Latest Funding Round
    $30 M (USD), Series C

    Nov 16, 2023

  • Investors
    Olympus

    & 12 more

  • Employee Count
    29

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of On Target Laboratories

On Target Laboratories offers a comprehensive portfolio of products and services, including CYTALUX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

FDA-approved agent for detecting and illuminating tumors during cancer surgery.

People of On Target Laboratories
Headcount 10-50
Employee Profiles 17
Employee Profiles
People
Christopher Seekamp
Director of Process Development, CMC
People
Jessica Todd
Vice President Marketing
People
Philip Low
Co-Founder and Chief Science Officer
People
Pravin Gagare
Director, CMC

Unlock access to complete

Funding Insights of On Target Laboratories

On Target Laboratories has successfully raised a total of $116.5M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series C — $30.0M
  • First Round

    (11 Mar 2014)

  • Investors Count 13
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Series C - On Target Laboratories Valuation Johnson & Johnson Innovation , Pension Fund
Mar, 2021 Amount Series B - On Target Laboratories Valuation Johnson & Johnson Innovation – JJDC , H.I.G. Capital
Mar, 2018 Amount Series B - On Target Laboratories Valuation HIG BioHealth Partners , Elevate Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in On Target Laboratories

On Target Laboratories has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Olympus, HHS and H.I.G. Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage healthcare investments are made by 3B Future Health Fund.
Founded Year Domain Location
Early-stage investments are made in diverse sectors by the firm.
Founded Year Domain Location
Venture capital firm backed by Johnson & Johnson
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by On Target Laboratories

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - On Target Laboratories

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

On Target Laboratories Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of On Target Laboratories

On Target Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics, Averto Medical, Guerbet and C-RAD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Neurosurgery robots are provided for neurological disorder treatments.
domain founded_year HQ Location
Developer of fluorescence-guided imaging technologies to help surgeons detect residual cancer tissue during operations
domain founded_year HQ Location
Medical devices for gastrointestinal disease patients are developed.
domain founded_year HQ Location
Contrast agents and delivery systems are developed for medical imaging.
domain founded_year HQ Location
Oncology treatments are delivered through standalone clinics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about On Target Laboratories

When was On Target Laboratories founded?

On Target Laboratories was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is On Target Laboratories located?

On Target Laboratories is headquartered in West Lafayette, United States. It is registered at West Lafayette, Indiana, United States.

Who is the current CEO of On Target Laboratories?

Chris Barys is the current CEO of On Target Laboratories.

Is On Target Laboratories a funded company?

On Target Laboratories is a funded company, having raised a total of $116.5M across 8 funding rounds to date. The company's 1st funding round was a Series B of $11.1M, raised on Mar 11, 2014.

How many employees does On Target Laboratories have?

As of Dec 31, 2023, the latest employee count at On Target Laboratories is 29.

What does On Target Laboratories do?

On Target Laboratories was founded in 2010 in West Lafayette, United States. Focus is placed on the biotechnology sector, where molecular imaging agents are developed to assist in cancer surgery. Fluorescent markers based on this technology are supplied to highlight cancerous tissue during procedures, allowing for targeted removal. Key roles are held by Phil S. Low as Founder and Chief Science Officer, and Chris Barys as CEO and President.

Who are the top competitors of On Target Laboratories?

On Target Laboratories's top competitors include Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics and Guerbet.

What products or services does On Target Laboratories offer?

On Target Laboratories offers CYTALUX.

Who are On Target Laboratories's investors?

On Target Laboratories has 13 investors. Key investors include Olympus, HHS, H.I.G. Capital, Johnson & Johnson Innovation, and Pension Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available